Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/357
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMARCHINI, Giovanni S.-
dc.contributor.authorVICENTINI, Fabio C.-
dc.contributor.authorMAZZUCCHI, Eduardo-
dc.contributor.authorBRITO, Arthur-
dc.contributor.authorEBAID, Gustavo-
dc.contributor.authorSROUGI, Miguel-
dc.date.accessioned2013-07-30T14:39:08Z-
dc.date.available2013-07-30T14:39:08Z-
dc.date.issued2012-
dc.identifier.citationUROLOGY, v.79, n.2, p.304-308, 2012-
dc.identifier.issn0090-4295-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/357-
dc.description.abstractOBJECTIVE To report our experience with silent ureteral stones and expose their true influence on renal function. METHODS We analyzed 506 patients who had undergone ureterolithotripsy from January 2005 to May 2010. Silent ureteral stones were calculi found in the absence of any specific or subjective ureteral stone-related symptoms. Of the 506 patients, 27 (5.3%) met these criteria (global cohort). All patients were assessed postoperatively with dimercaptosuccinic acid scintigraphy (DMSA). A difference in relative kidney function of >10% was considered abnormal. Pre- and postoperative comparative DMSA analyses were electively obtained for 9 patients (kidney function cohort). A t test was used to assess the numeric variables, and the chi-square test or Fisher's exact test was used for categorical variables. Two-tailed P < .05 was considered statistically significant. RESULTS Stones were diagnosed by radiologic abdominal evaluation for nonurologic diseases in 40% and after previous nephrolithiasis treatment in 33%. The primary therapy was ureterolithotripsy in 88%. The mean follow-up time was 23 months. The overall ureteral stone-free rate after 1 and 2 procedures was 96% and 100%, respectively. In the global cohort, the mean pre- and postoperative serum creatinine levels were similar (P = .39), and the mean postoperative function on DMSA was 31%. In the kidney function cohort, no difference was found between the pre-and postoperative DMSA findings (22% +/- 12.1% vs 20% +/- 11.8%; P = .83) and serum creatinine (0.8 +/- 0.13 mg/dL vs 1.0 +/- 0.21 mg/dL; P = .45). CONCLUSION Silent ureteral stones are associated with decreased kidney function present at the diagnosis. Hydronephrosis tends to diminish after stone removal, and kidney function remains unaltered. UROLOGY 79: 304-309, 2012. (C) 2012 Elsevier Inc.-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE INC-
dc.relation.ispartofUrology-
dc.rightsrestrictedAccess-
dc.subject.othershock-wave lithotripsy-
dc.subject.otherprevalence-
dc.subject.otherurolithiasis-
dc.subject.otherobstruction-
dc.subject.othercalculi-
dc.titleSilent Ureteral Stones: Impact on Kidney Function-Can Treatment of Silent Ureteral Stones Preserve Kidney Function?-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE INC-
dc.identifier.doi10.1016/j.urology.2011.07.1436-
dc.identifier.pmid22055694-
dc.subject.wosUrology & Nephrology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage304-
hcfmusp.description.endpage308-
hcfmusp.description.issue2-
hcfmusp.description.volume79-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84856730257-
hcfmusp.origem.idWOS:000300407200027-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceANDRENSANDBERG A, 1983, SCAND J UROL NEPHROL, V17, P81-
hcfmusp.relation.referenceGLOWACKI LS, 1992, J UROLOGY, V147, P319-
hcfmusp.relation.referenceHesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9-
hcfmusp.relation.referenceIrving SO, 2000, BJU INT, V85, P637, DOI 10.1046/j.1464-410x.2000.00563.x-
hcfmusp.relation.referenceJungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014-
hcfmusp.relation.referenceKeeley FX, 2001, BJU INT, V87, P1, DOI 10.1046/j.1464-410x.2001.00781.x-
hcfmusp.relation.referenceKELLEHER JP, 1991, BRIT J UROL, V67, P125, DOI 10.1111/j.1464-410X.1991.tb15092.x-
hcfmusp.relation.referenceMAHMOUD AH, 1991, CLIN NUCL MED, V16, P162, DOI 10.1097/00003072-199103000-00005-
hcfmusp.relation.referenceStamatelou KK, 2003, KIDNEY INT, V63, P1951-
hcfmusp.relation.referenceStreem SB, 1996, J UROLOGY, V155, P1186, DOI 10.1016/S0022-5347(01)66208-6-
hcfmusp.relation.referenceTrinchieri A, 2000, EUR UROL, V37, P23, DOI 10.1159/000020094-
hcfmusp.relation.referenceWeizer AZ, 2002, J UROLOGY, V168, P46, DOI 10.1016/S0022-5347(05)64829-X-
hcfmusp.relation.referenceWimpissinger F, 2007, J UROLOGY, V178, P1341, DOI 10.1016/j.juro.2007.05.128-
dc.description.indexMEDLINE-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus15-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCG
Departamento de Cirurgia - FM/MCG

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/55
LIM/55 - Laboratório de Urologia


Files in This Item:
File Description SizeFormat 
art_MARCHINI_Silent_Ureteral_Stones_Impact_on_Kidney_Function_Can_2012_eng.pdf
  Restricted Access
publishedVersion (English)172.86 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.